AF without thrombus | AF with thrombus | p-value | |
---|---|---|---|
(n = 125) | (n = 15) | ||
Clinical parameters | |||
Age (year) | 62.1 ± 9.6 | 65.3 ± 9.0 | 0.23 |
Male, n (%) | 93 (74) | 12 (80) | 0.64 |
Smoking, n (%) | 21 (17) | 5 (33) | 0.16 |
Diabetes Mellitus, n (%) | 9 (7) | 1 (7) | >0.99 |
Hypertension, n (%) | 56 (45) | 10 (67) | 0.11 |
Dyslipidemia, n (%) | 27 (21) | 1 (7) | 0.30 |
CHADS2 score = 1 | 88 (71) | 14 (93) | 0.059 |
AF duration (year) | 5.9 ± 5.7 | 6.3 ± 3.4 | 0.83 |
PT-INR | 1.89 ± 0.49 | 1.84 ± 0.35 | 0.65 |
PT-INR met guideline, n (%) | 68 (54) | 11 (73) | 0.18 |
Echocardiographic parameters | |||
LVEF (%) | 59.1 ± 6.6 | 57.3 ± 4.8 | 0.29 |
LAD (mm) | 46.0 ± 6.7 | 49.5 ± 7.5 | 0.064 |
Maximum LAA volume (ml) | 10.2 ± 4.7 | 17.9 ± 8.1 | <0.001 |
Minimum LAA volume (ml) | 7.0 ± 3.8 | 14.8 ± 7.1 | <0.001 |
SEC score (0-4 grade) | 1 (1 – 1) | 1 (1 – 2) | 0.047 |
LAAPV (cm/sec) | 31.9 ± 12.2 | 23.0 ± 8.3 | 0.007 |
LAA peak longitudinal strain | 9.3 ± 5.6 | 2.5 ± 1.5 | <0.001 |
LAAEF (%) | 33.5 ± 10.7 | 17.9 ± 3.6 | <0.001 |